Burrows R B, Brown G M
J Bacteriol. 1978 Nov;136(2):657-67. doi: 10.1128/jb.136.2.657-667.1978.
Two enzymes have been partially purified from extracts of Escherchia coli B which together catalyze the conversion of the product of the action of GTP cyclohydrolase II, 2,5-diamino-6-oxy-4-(5'-phosphoribosylamine)pyrimidine, to 5-amino-2,6-dioxy-4-(5'-phosphoribitylamine)pyrimidine. These two compounds are currently thought to be intermediates in the biosynthesis of riboflavin. The enzymatic conversion occurs in two steps. The product of the action of GTP cyclohydrolase II first undergoes hydrolytic deamination at carbon 2 of the ring, followed by reduction of the ribosylamino group to a ribitylamino group. The enzyme which catalyzes the first step, herein called the "deaminase," has been purified 200-fold. The activity was assayed by detecting the conversion of the product of the reaction catalyzed by GTP cyclohydrolase II to a compound which reacts with butanedione to form 6,7-dimethyllumazine. The enzyme has a molecular weight of approximately 80,000 and a pH optimum of 9.1. The dephosphorylated form of the substrate is not deaminated in the presence of the enzyme. The assay for the enzyme which catalyzes the second step, referred to here as the "reductase," involves the detection of the conversion of the product of the deaminase-catalyzed reaction to a compound which, after treatment with alkaline phosphatase, reacts with butanedione to form 6,7-dimethyl-8-ribityllumazine. The reductase has a molecular weight of approximately 40,000 and a pH optimum of 7.5. Like the deaminase, the reductase does not act on the dephosphorylated form of its substrate. Reduced nicotinamide adenine dinucleotide phosphate is required as a cofactor; reduced nicotinamide adenine dinucleotide can be used about 30% as well as the phosphate form. The activity of neither enzyme is inhibited by riboflavin, FMN, or flavine adenine dinucleotide.
已从大肠杆菌B提取物中部分纯化出两种酶,它们共同催化将GTP环水解酶II作用的产物2,5-二氨基-6-氧代-4-(5'-磷酸核糖胺)嘧啶转化为5-氨基-2,6-二氧代-4-(5'-磷酸核糖醇胺)嘧啶。目前认为这两种化合物是核黄素生物合成的中间体。酶促转化分两步进行。GTP环水解酶II作用的产物首先在环的2位进行水解脱氨,然后将核糖氨基还原为核糖醇氨基。催化第一步的酶,在此称为“脱氨酶”,已纯化了200倍。通过检测GTP环水解酶II催化反应的产物转化为与丁二酮反应形成6,7-二甲基鲁米诺嗪的化合物来测定活性。该酶的分子量约为80,000,最适pH为9.1。在酶存在下,底物的去磷酸化形式不会被脱氨。催化第二步的酶,在此称为“还原酶”,其测定涉及检测脱氨酶催化反应的产物转化为一种化合物,该化合物在用碱性磷酸酶处理后与丁二酮反应形成6,7-二甲基-8-核糖醇鲁米诺嗪。还原酶的分子量约为40,000,最适pH为7.5。与脱氨酶一样,还原酶也不作用于其底物的去磷酸化形式。需要还原型烟酰胺腺嘌呤二核苷酸磷酸作为辅因子;还原型烟酰胺腺嘌呤二核苷酸的使用效率约为磷酸形式的30%。这两种酶的活性均不受核黄素、黄素单核苷酸或黄素腺嘌呤二核苷酸的抑制。